Phase 2 Study of VX-950, Pegasys®, and Copegus® in Hepatitis C
Public ClinicalTrials.gov record NCT00336479. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2 Study of VX-950 in Combination With Peginterferon Alfa-2a (Pegasys®), With Ribavirin (Copegus®) in Subjects With Genotype 1 Hepatitis C Who Have Not Received Prior Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Study the effectiveness of telaprevir (VX-950) in combination with Pegylated Interferon Alfa 2a (Peg-IFN-alfa-2a) and Ribavirin (RBV) in reducing plasma hepatitis C virus (HCV) ribonucleic acid (RNA) levels
Study identification
- NCT ID
- NCT00336479
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 263 participants
Conditions and interventions
Conditions
Interventions
- Telaprevir Drug
- Ribavirin Drug
- Pegylated Interferon Alfa 2a Drug
- Placebo Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2006
- Primary completion
- Jan 31, 2008
- Completion
- Jan 31, 2008
- Last update posted
- Jul 22, 2014
2006 – 2008
United States locations
- U.S. sites
- 36
- U.S. states
- 20
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Call For Information | Phoenix | Arizona | — | — |
| Cedars-Sinai Medical Center | Los Angeles | California | — | — |
| Stanford University Liver Research | Palo Alto | California | — | — |
| Call For Information | San Francisco | California | — | — |
| University of Colorado Hospital | Denver | Colorado | — | — |
| South Denver Gastroenterology | Englewood | Colorado | — | — |
| Shands Hospital University of Florida | Gainesville | Florida | 32610 | — |
| Call for Information | Miami | Florida | — | — |
| University of Chicago Medical Center | Chicago | Illinois | — | — |
| Clarian Hospital | Indianapolis | Indiana | 46202 | — |
| Gulf Coast Research Associates | Baton Rouge | Louisiana | — | — |
| Call For Information | Baltimore | Maryland | — | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | — | — |
| Call for Information | Boston | Massachusetts | — | — |
| Call For Information | Worcester | Massachusetts | — | — |
| Henry Ford Health System | Detroit | Michigan | — | — |
| Call For Information | Rochester | Minnesota | — | — |
| Saint Louis University | St Louis | Missouri | — | — |
| University of New Mexico | Albuquerque | New Mexico | — | — |
| Call For Information | Manhasset | New York | — | — |
| Call for Information | New York | New York | — | — |
| Columbia University Medical Center | New York | New York | — | — |
| Call For Information | Chapel Hill | North Carolina | — | — |
| Call For Information | Durham | North Carolina | — | — |
| University of Cincinnati College of Medicine | Cincinnati | Ohio | — | — |
| Fox Chase/ Temple Cancer Center | Philadelphia | Pennsylvania | 19140 | — |
| University of Pennsylvania Hospital | Philadelphia | Pennsylvania | — | — |
| Baylor University Medical Center | Dallas | Texas | — | — |
| Methodist Hospital of Dallas | Dallas | Texas | — | — |
| University of Texas Southwestern Medical Center at Dallas | Dallas | Texas | — | — |
| Alamo Medical Research | San Antonio | Texas | 78215 | — |
| Inova Fairfax Hospital | Annandale | Virginia | 22003 | — |
| University of Virginia Health System | Charlotteville | Virginia | — | — |
| Metropolitan Research | Fairfax | Virginia | 22031 | — |
| McGuire VA Medical Center | Richmond | Virginia | 23249 | — |
| Froedtert Memorial Lutheran Hospital | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00336479, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2014 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00336479 live on ClinicalTrials.gov.